| 晚期胃癌ERCC1和BRCA1表达与铂类化疗疗效及预后关系 |
| |
| 引用本文： | 顾术东,茅国新,张曙. 晚期胃癌ERCC1和BRCA1表达与铂类化疗疗效及预后关系[J]. 陕西肿瘤医学, 2013, 0(11): 2525-2528 |
| |
| 作者姓名： | 顾术东 茅国新 张曙 |
| |
| 作者单位： | [1]南通大学附属医院肿瘤化疗科,江苏南通226001 [2]南通大学附属医院病理科,江苏南通226001 |
| |
| 摘 要： | 目的：探讨晚期胃癌癌组织中切除修复交叉互补基因1（excision repair cross-complementing gene 1,ERCC1）和乳腺癌易感基因l（breast cancer susceptibility gene 1,BRCA1）的表达状况及其与患者临床病理特征、铂类方案化疗疗效及预后之间的关系.方法：采用免疫组化方法检测晚期胃癌癌组织中ERCC1和BRCA1蛋白的表达状况.结果：晚期胃癌癌组织中ERCC1和BRCA1蛋白表达阳性率分别为28.9％和19.0％.ERCC1和BRCA1蛋白的表达与患者的年龄、性别、PS评分及肿瘤分化程度均无关（P＞0.05）,胃癌癌组织中ERCC1蛋白表达与BRCA1蛋白表达呈正相关（r=0.248,P=0.006）.ERCC1和BRCA1蛋白表达阴性患者铂类方案化疗有效率高于表达阳性患者（P＜0.05）.ERCC1和BRCA1蛋白表达阴性患者化疗后,中位生存期高于表达阳性患者（P＜0.05）.COX回归模型分析结果显示ERCC1和BRCA1蛋白的表达状态及肿瘤分化程度是影响胃癌预后的独立因素.结论：晚期胃癌ERCC1和BRCA1蛋白的表达状态可作为化疗方案的选择及预后判断的依据.
|
| 关 键 词： | 胃癌 ERCC1 BRCA1 铂类 预后 |
Correlation of expressions of ERCC1 and BRCA1 with efficacy of platinum chemotherapy and prognosis in advanced gastric cancer |
| |
| Gu Shudong,Mao Guoxin,Zhang Shu. Correlation of expressions of ERCC1 and BRCA1 with efficacy of platinum chemotherapy and prognosis in advanced gastric cancer[J]. Shaanxi Oncology Medicine, 2013, 0(11): 2525-2528 |
| |
| Authors: | Gu Shudong Mao Guoxin Zhang Shu |
| |
| Affiliation: | 1.Department of Tumor Chemotherapy, Affiliated Hospital of Nantong University, Jiangsu Nantong 226001, China; 2.Department of Pathology, Affiliated Hospital of Nantong University, Jiangsu Nantong 226001, China;) |
| |
| Abstract: | Objective：To study the expressions of ERCC1 and BRCA1 in advanced gastric cancer and their correlation with clinicopathological features,efficacy of platinum chemotherapy and prognosis.Methods：Expressions of ERCC1 and BRCA1 proteins in the tissues of advanced gastric cancer were measured by immunohistochemistry.Results：The positive rate of ERCC1 and BRCA1 proteins was 28.9％ and 19.0％ respectively.The expressions of ERCC1 and BRCA1 proteins were not associated with the patient＇s gender,age,PS score and differentiation degree （P ＞ 0.05）.The positive expression of ERCC1 protein had a significantly positive correlation with BRCA1 protein in advanced gastric cancer（r =0.248,P =0.006）.The response rate of chemotherapy in ERCC1 and BRCA1 proteins negative patients was significantly higher than the rate in ERCC1 and BRCA1 positive patients（P ＜ 0.05）.Compared with ERCC1 and BRCA1 positive patients,ERCC1 and BRCA1 negative patients had longer median survival time with statistical difference （P ＜ 0.05）.COX multivariate analysis confirmed that the status of ERCC1 and BRCA1 proteins expressions and differentiation degree were independently correlated with prognosis in advanced gastric cancer.Conclusion：Expressions of ERCC1 and BRCA1 proteins might be useful in the choice of chemotherapy regimens and evaluation of prognosis for patients with advanced gastric cancer. |
| |
| Keywords: | gastric cancer ERCC1 BRCA1 platinum prognosis |
| 本文献已被 维普 等数据库收录！ |
|
